Global tech giant Samsung has collaborated with decentralized science (DeSci) and healthcare artificial intelligence protocol Galeon to leverage AI training data from its ultrasound devices.
In a recent announcement shared with Cointelegraph, Samsung revealed its partnership with Galeon to integrate its ultrasound equipment with Galeon’s electronic health record (EHR) platform. Galeon CEO Loïc Brotons mentioned that the EHR platform is currently operational in 18 interconnected hospitals, including prominent institutions in France such as Rouen University Hospital, Caen University Hospital, Toulon Hospital, and Sud Francilien Hospital.
The collaboration between Samsung and Galeon focuses on enhancing medical data accessibility while prioritizing data privacy. Brotons emphasized that the data is not stored on the blockchain; only the AI algorithm operates on the blockchain with complete transparency regarding its operations. All data undergoes anonymization before being used for training to comply with privacy regulations.
This partnership enables healthcare providers to train AI models without centralizing patient information, allowing each hospital or institution to maintain control over its data while benefiting from shared algorithm training.
![\"Samsung,](\"https://cnews24.ru/uploads/770/770330d7848deca82433a28e24c75199ccc0b216.jpg\" "\\"\\"")
The Galeon Team. Source: Galeon
Related: Blockchain and AI can enable advanced personalization in healthcare
Decentralized science revolutionizing healthcare
The healthcare industry has witnessed significant activity in decentralized science. Alex Dobrin, awareness steward at VitaDAO, a decentralized collective dedicated to extending human lifespans, highlighted that the time and cost constraints of drug development are prompting individuals to take proactive measures.
Earlier this year, DeSci decentralized autonomous organization HydraDAO reported a breakthrough in one of its research projects, where rats with fully transected spines were able to walk again within five days. Such advancements are attracting attention from investors.
Related: Decentralized science meets AI — legacy institutions aren’t ready
Investor interest in DeSci platforms
DeSci platform Bio Protocol recently secured funding from investors, including Maelstrom Fund and Animoca Brands, in a $6.9 million funding round. This follows a previous investment from Binance Labs, the venture capital arm of the cryptocurrency exchange, at the end of 2024.
Data plays a crucial role in these projects, with DeSci platforms actively seeking to obtain genetic data from bankrupt DNA testing service 23andMe.
Magazine: Memecoin degeneracy is funding groundbreaking anti-aging research
